These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 25529104)
1. Why are anti-obesity drugs stigmatized? Halpern B; Halpern A Expert Opin Drug Saf; 2015 Feb; 14(2):185-9. PubMed ID: 25529104 [TBL] [Abstract][Full Text] [Related]
2. Update on obesity pharmacotherapy. Bray GA; Ryan DH Ann N Y Acad Sci; 2014 Apr; 1311():1-13. PubMed ID: 24641701 [TBL] [Abstract][Full Text] [Related]
3. Safety assessment of FDA-approved (orlistat and lorcaserin) anti-obesity medications. Halpern B; Halpern A Expert Opin Drug Saf; 2015 Feb; 14(2):305-15. PubMed ID: 25563411 [TBL] [Abstract][Full Text] [Related]
4. Do we need anti-obesity drugs? Hainer V; Hainerová IA Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():8-20. PubMed ID: 23280861 [TBL] [Abstract][Full Text] [Related]
5. Should the Same Safety Scrutiny of Antiobesity Medications be Applied to Other Chronic Usage Drugs? Halpern B; Mancini MC Obesity (Silver Spring); 2020 Jul; 28(7):1171-1172. PubMed ID: 32374528 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological treatment of obesity in children and adolescents: current status and perspectives. Catoira N; Nagel M; Di Girolamo G; Gonzalez CD Expert Opin Pharmacother; 2010 Dec; 11(18):2973-83. PubMed ID: 20958104 [TBL] [Abstract][Full Text] [Related]
7. Reducing the risk of obesity: defining the role of weight loss drugs. Ling H; Lenz TL; Burns TL; Hilleman DE Pharmacotherapy; 2013 Dec; 33(12):1308-21. PubMed ID: 23712541 [TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy for the management of obesity. Patel D Metabolism; 2015 Nov; 64(11):1376-85. PubMed ID: 26342499 [TBL] [Abstract][Full Text] [Related]
9. [Current status of medical therapy for obesity and the potential of novel anti-obesity drug development]. Nakazato M Nihon Rinsho; 2013 Feb; 71(2):324-8. PubMed ID: 23631215 [TBL] [Abstract][Full Text] [Related]
10. Long-term pharmacotherapy for obesity. Klein S Obes Res; 2004 Dec; 12 Suppl():163S-6S. PubMed ID: 15687412 [TBL] [Abstract][Full Text] [Related]
11. The safety and efficacy of lorcaserin in the management of obesity. Hess R; Cross LB Postgrad Med; 2013 Nov; 125(6):62-72. PubMed ID: 24200762 [TBL] [Abstract][Full Text] [Related]
12. Anti-obesity drugs: a review about their effects and their safety. Derosa G; Maffioli P Expert Opin Drug Saf; 2012 May; 11(3):459-71. PubMed ID: 22439841 [TBL] [Abstract][Full Text] [Related]
16. New and emerging drug molecules against obesity. George M; Rajaram M; Shanmugam E J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):65-76. PubMed ID: 24064009 [TBL] [Abstract][Full Text] [Related]
17. Past, Present, and Future of Pharmacologic Therapy in Obesity. Rodríguez JE; Campbell KM Prim Care; 2016 Mar; 43(1):61-7, viii. PubMed ID: 26896200 [TBL] [Abstract][Full Text] [Related]
18. An update on the pharmacological treatment of obesity. Schnee DM; Zaiken K; McCloskey WW Curr Med Res Opin; 2006 Aug; 22(8):1463-74. PubMed ID: 16870072 [TBL] [Abstract][Full Text] [Related]
19. Weight loss medications--where do they fit in? Dixon JB Aust Fam Physician; 2006 Aug; 35(8):576-9. PubMed ID: 16894428 [TBL] [Abstract][Full Text] [Related]
20. A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial. Fidler MC; Sanchez M; Raether B; Weissman NJ; Smith SR; Shanahan WR; Anderson CM; J Clin Endocrinol Metab; 2011 Oct; 96(10):3067-77. PubMed ID: 21795446 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]